Drug · DIN 02569825
SCENESSE
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since July 9, 2026.
- Drug Identification Number (DIN)
- 02569825
- Company (DIN owner)
- Clinuvel, Inc.Burlingame, California, United States
- Schedule
- Prescription
- Dosage form
- Implant
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Afamelanotide D02BB02
- Class
- Human
- Record last updated
- August 28, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AFAMELANOTIDE (AFAMELANOTIDE ACETATE) | 16 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 9, 2026: NOC 37875New Drug Submission (NDS)